C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 1 filers reported holding C4 THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $17,795,000 | 7.09% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $60,745,000 | 3.44% |
| Soleus Capital Management, L.P. | 464,068 | $17,166,000 | 3.09% |
| Cormorant Asset Management, LP | 2,490,065 | $92,107,000 | 2.05% |
| P.A.W. CAPITAL CORP | 50,000 | $1,850,000 | 1.63% |
| Perceptive Advisors | 3,158,566 | $116,835,000 | 1.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 497,136 | $18,389,000 | 1.41% |
| Mizuho Securities Co. Ltd. | 169,392 | $6,266,000 | 1.30% |
| RTW INVESTMENTS, LP | 2,149,228 | $79,437,000 | 1.24% |
| Darwin Global Management, Ltd. | 140,034 | $5,180,000 | 1.01% |